Access barriers and ethical challenges of therapeutic decision-making in patients with inflammatory bowel disease and prior malignancy: a case series
Revista de Gastroenterología del Perú · 29.03.2026 · 46 (1) · 14-19
DOI: 10.47892/rgp.2026.461.2047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista de Gastroenterología del Perú, online erschienen am 29.03.2026. Verfasst von Larissa Leandro Medeiros und 8 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To report a case series of patients with inflammatory bowel diseases and a history of malignancy and to analyze how this condition influenced therapeutic decisionmaking presents a challenging scenario. Materials and methods: This was a retrospective observational study analyzing 11 patients with inflammatory bowel disease and malignant neoplasms followed at an inflammatory bowel disease outpatient clinic of a university hospital. Clinical, therapeutic, and oncologic findings are reported descriptively based on medical record review.
Results
Seven patients (64%) had ulcerative colitis, and six (55%) were female, with a mean age of 47 years. Extra-intestinal neoplasms predominated. Six patients (55%) received advanced therapy near the time of cancer diagnosis; reintroduction was possible in four cases. Judicial action was required for two patients.
Conclusions
Clinical decision-making in patients with inflammatory bowel disease and a history of malignancy is an individualized process, based on multidisciplinary discussion, bioethical considerations, and the most reliable available evidence, even in the face of state-imposed logistical obstacles. Continuous updating of Clinical Protocols and Therapeutic Guidelines is essential to ensure equitable access to the most appropriate and non-harmful treatment for this patient group.
Zitieren
APA
Medeiros, L. L., Souza, T. Q., Faria, M. L. C. D., Faria, R. J. D., Bortoli, Z. B., Lopes, A. C. B., Martins, B. A. A., Carneiro, M. D. V., & Jorge, C. C. (2026). Access barriers and ethical challenges of therapeutic decision-making in patients with inflammatory bowel disease and prior malignancy: a case series. Revista de Gastroenterología del Perú, 46(1), 14-19. https://doi.org/10.47892/rgp.2026.461.2047
Vancouver
Medeiros LL, Souza TQ, Faria MLCD, Faria RJD, Bortoli ZB, Lopes ACB, et al. Access barriers and ethical challenges of therapeutic decision-making in patients with inflammatory bowel disease and prior malignancy: a case series. Revista de Gastroenterología del Perú. 2026;46(1):14-19. doi:10.47892/rgp.2026.461.2047
BibTeX
@article{Medeiros2026,
author = {Medeiros, Larissa Leandro and Souza, Thales Queiroz and Faria, Maria Luiza Cronemberger de and Faria, Ricardo Jacarandá de and Bortoli, Zuleica Barrio and Lopes, Ana Carolina Benvindo and Martins, Bruno Augusto Alves and Carneiro, Marcos De Vasconcelos and Jorge, Caio Cardozo},
title = {Access barriers and ethical challenges of therapeutic decision-making in patients with inflammatory bowel disease and prior malignancy: a case series},
journal = {Revista de Gastroenterología del Perú},
year = {2026},
volume = {46},
number = {1},
pages = {14--19},
doi = {10.47892/rgp.2026.461.2047}
}
EUVIMED